Much of the positive momentum might already be factored in
In late October 2025, Cameco — one of the world's foremost uranium suppliers — saw its shares surge to a record high after signing a binding agreement with the U.S. Department of Commerce, backed by $80 billion in federal funding to accelerate nuclear reactor construction across America. The moment marks more than a corporate milestone; it reflects a broader civilizational reckoning with energy, as governments increasingly turn to nuclear power to meet the insatiable demands of artificial intelligence and digital infrastructure. For Cameco, the arc from uranium mine to national energy policy is now unmistakably direct — though history reminds us that the distance between a promising catalyst and a fully realized return is rarely as short as a single day's rally suggests.
- A single binding agreement with the U.S. government sent Cameco's stock soaring 23% in one session, erasing any doubt that nuclear energy has returned to the center of American energy policy.
- The $80 billion federal commitment to new reactor construction — using Westinghouse technology that Cameco co-owns — transforms the company from a commodity supplier into a structural pillar of national infrastructure.
- Cameco's Q2 earnings shattered expectations with 47% revenue growth and a 41.7% earnings-per-share beat, with Westinghouse swinging from a $47M loss to $126M in profit in just one year.
- The stock has climbed 83% in 2025 alone, vastly outpacing the broader market, yet its valuation at 84 times forward earnings forces a hard question: is the future already fully priced into today's share price?
- Wall Street's consensus remains a strong buy with 11 of 16 analysts bullish, but the gap between enthusiasm and valuation discipline is where the real risk quietly lives.
On October 28th, Cameco's stock closed at $110.16 — a record high — after the Canadian uranium giant and Brookfield Asset Management signed a binding agreement with the U.S. Department of Commerce to accelerate nuclear power deployment nationwide. The deal, backed by at least $80 billion in government funding, aligned with executive orders signed earlier in the year and positioned Cameco as a central beneficiary of what appears to be a decisive national pivot toward nuclear energy.
The mechanics are direct: federal money will flow toward new reactor construction using Westinghouse's advanced technology, including financing for long-lead components. Westinghouse — acquired jointly by Brookfield and Cameco in late 2023 — will supply the reactors, which are intended to power the growing energy demands of data centers and AI infrastructure. For Cameco, more reactors means more demand for uranium fuel, and the company already ranks among the world's largest high-grade uranium reserve holders.
The financial momentum behind the story is real. Cameco's second-quarter revenue rose 47% year-over-year to 877 million Canadian dollars, uranium sales volumes jumped 40%, and Westinghouse swung from a 47 million CAD loss to 126 million CAD in net earnings — a turnaround anchored by new reactor work in the Czech Republic. Adjusted earnings per share beat Wall Street's consensus by nearly 42%. The stock has gained 83% in 2025 alone, dwarfing the S&P 500's 16% year-to-date return.
Yet the valuation demands scrutiny. At 84 times forward earnings and over 17 times sales, Cameco trades at a steep premium that raises the perennial investor's dilemma: how much of a compelling growth story is already embedded in the price? The company carries a solid balance sheet — 716 million CAD in cash, 1 billion CAD in debt, and an undrawn 1 billion CAD credit facility — and management projects steady uranium production through 2025. Wall Street remains broadly bullish, with 15 of 16 analysts recommending a buy, and a consensus price target implying 13% further upside. But the distance between a genuine catalyst and a fully realized return is rarely as short as a single record-breaking session.
On October 28th, shares of Cameco jumped 23 percent in a single day, closing at $110.16—a record high for the Canadian uranium company. The catalyst was concrete: Cameco and Brookfield Asset Management had just signed a binding agreement with the U.S. Department of Commerce to accelerate nuclear power deployment across America, backed by at least $80 billion in government funding for new reactor construction. The deal aligned with executive orders signed in May, positioning the uranium supplier as a central player in what appears to be a major national pivot toward nuclear energy.
The mechanics of the arrangement are straightforward. The U.S. government will channel money toward building new reactors using Westinghouse's advanced reactor technology, including near-term financing for long-lead components. Westinghouse itself—acquired by Brookfield and Cameco in November 2023—is a global leader in nuclear innovation. Once operational, these reactors are meant to supply stable, clean power to the growing infrastructure demands of data centers and AI computing facilities across the country. For Cameco, which ranks among the world's top uranium and nuclear fuel suppliers, the implication is direct: as nuclear capacity expands, demand for fuel will follow.
Cameco's recent performance already reflects this momentum. Over the past year, the stock has climbed 79 percent, with an 83 percent gain in 2025 alone—a trajectory that dwarfs the S&P 500's 13 percent annual return and 16 percent year-to-date performance. The company itself is substantial: Canada-based, with roughly $40 billion in market capitalization, it owns some of the world's largest high-grade uranium reserves and operates low-cost production sites. Its business spans three segments—Uranium, Fuel Services, and a 49 percent stake in Westinghouse—serving utilities globally.
The earnings picture supports the enthusiasm. In the second quarter, ended June 30, Cameco reported revenue of 877 million Canadian dollars ($634.1 million), up 47 percent year-over-year. Uranium segment revenues jumped 47 percent to 705 million CAD, with sales volume hitting 8.7 million pounds, up 40 percent from the prior year. The Fuel Services division also grew, climbing 37 percent annually to 162 million CAD. Most notably, Westinghouse swung back to profitability, posting net earnings of 126 million CAD, compared to a 47 million CAD loss a year earlier—a turnaround driven by work on two new reactors at the Dukovany power plant in the Czech Republic. Adjusted earnings per share reached 0.71 Canadian dollars ($0.51), crushing Wall Street's consensus estimate by 41.7 percent.
Yet the valuation tells a different story. At 84.21 times forward earnings and 17.17 times sales, Cameco trades at a steep premium to sector averages. These multiples raise a legitimate question: how much of the company's growth story is already baked into the current price? The company holds 716 million CAD in cash and cash equivalents, 1 billion CAD in total debt, and has access to an additional 1 billion CAD undrawn credit facility—a solid balance sheet. Management expects uranium production of 18 million pounds each from its McArthur River/Key Lake and Cigar Lake operations in fiscal 2025.
Wall Street remains decidedly bullish. Of 16 analysts covering the stock, 11 assign a "Strong Buy" rating, four recommend "Moderate Buy," and one suggests "Hold." The consensus price target is $107.12, implying 13 percent upside from current levels, though the Street-high target reaches $130, suggesting 37 percent potential gain. The enthusiasm reflects confidence in both the company's fundamentals and the broader tailwind from government-backed nuclear expansion. Still, investors face a familiar tension: a company with genuine growth catalysts and solid earnings, but a price that may already reflect years of that growth.
Notable Quotes
As nuclear expansion ramps up worldwide, the company is positioned to benefit from strong demand for fueling next-generation reactors across both domestic and international markets.— Barchart analysis
The Hearth Conversation Another angle on the story
Why did the stock jump so dramatically on this one announcement? Cameco was already climbing before October 28th.
The binding agreement with the Commerce Department wasn't just a press release—it was $80 billion in committed government money for nuclear reactors, with Cameco positioned as the fuel supplier. That's not speculation. That's infrastructure spending that requires uranium.
But the company was already profitable and growing. What changed?
The scale changed. Before this, Cameco was benefiting from general enthusiasm for nuclear energy and rising uranium prices. Now there's a specific, government-backed demand signal. Data centers and AI facilities need enormous amounts of power, and the government is saying nuclear is how we'll supply it.
So the valuation at 84 times forward earnings—is that justified?
That's the tension. The earnings are real, the growth is real, but you're paying for several years of that growth upfront. If nuclear expansion happens exactly as planned, the stock might be cheap. If there are delays or if sentiment shifts, you've paid a premium for something that hasn't materialized yet.
What would make you nervous as an investor?
Execution risk. Building reactors takes time and money. Regulatory approval can stall. And uranium prices, which drove much of Q2's revenue growth, could fall if supply increases faster than demand. The company is solid, but the stock price assumes everything goes right.